Tranquillizers, Sedatives, Hypnotics and Stimulants: Application (UGC-NET Unit IV)

Medium-band UGC-NET Forensic Science Paper II Unit IV drill on the application of sedative-hypnotic and stimulant toxicology. The set covers benzodiazepines (diazepam, lorazepam, alprazolam, midazolam, clonazepam, flunitrazepam, nitrazepam and oxazepam) at the receptor level (GABA-A chloride channel modulation, flumazenil as competitive antagonist) and at the analytical level (urine immunoassay screen with LC-MS/MS confirmation, the well-known false-negative on routine benzodiazepine immunoassays for clonazepam, lorazepam and flunitrazepam). Barbiturates (phenobarbital, pentobarbital and thiopental) appear with CYP3A4 induction, withdrawal severity, and the thiopental narco-analysis question in Indian jurisprudence. Neuroleptics include chlorpromazine, haloperidol, olanzapine and risperidone with their receptor-binding profiles. Hypnotics cover the Z-drugs (zolpidem, zopiclone) and gamma-hydroxybutyrate (GHB) as a date-rape agent. Stimulants cover amphetamine, methamphetamine, MDMA and MDA, methylphenidate (Ritalin), cocaine and its benzoylecgonine metabolite, khat-derived cathinone, and pseudoephedrine as a precursor. Indian context covers NDPS Act schedule placements, controlled-precursor status of pseudoephedrine and ephedrine, and the AIIMS-CFSL workflow for drug-facilitated sexual assault casework. SAMHSA cut-offs, segmental hair LC-MS/MS, and metabolic pathways through CYP3A4 and CYP2D6 are tested in applied scenario style.